Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Infections × lime × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Motor Activity 2 Breast Neoplasms 2 Weight Loss 1 Uterine Cervical Dysplasia 1 Polycystic Ovary Syndrome 1 Papillomavirus Infections 1 Obesity 1 Insulin Resistance 1 Infertility, Female 1 Infections 1 Cognitive Dysfunction 1

Interventions

Trimethoprim, Sulfamethoxazole Drug Combination 7 Ciprofloxacin 7 Vancomycin 4 Voriconazole 3 Fluconazole 3 Antibiotic Prophylaxis 3 Amoxicillin-Potassium Clavulanate Combination 3 plerixafor 2 gamma-Globulins 2 Therapeutics 2 Ribavirin 2 Polymerase Chain Reaction 2 Piperacillin, Tazobactam Drug Combination 2 Moxifloxacin 2 Levofloxacin 2 Lenalidomide 2 Immunoglobulins, Intravenous 2 Granulocyte Colony-Stimulating Factor 2 Fosfomycin 2 Filgrastim 2 Daptomycin 2 Cefepime 2 Caspofungin 2 ziprasidone 1 tocilizumab 1 threonic acid 1 telavancin 1 telaprevir 1 talquetamab 1 soybean oil, phospholipid emulsion 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02346227 2018-10-12

KINVAV

Universiteit Antwerpen

Phase 3 Completed

Uterine Cervical Dysplasia, Infections, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡